Investigation of the diversity of human papillomavirus 16 variants and L1 antigenic regions relevant for the prevention of human papillomavirus-related oropharyngeal cancer in Japan

被引:4
|
作者
Yoshida, Takuya [1 ,2 ]
Ogawa, Takenori [3 ]
Nakanome, Ayako [1 ]
Ohkoshi, Akira [1 ]
Ishii, Ryo [1 ]
Higashi, Kenjiro [1 ]
Ishikawa, Tomohiko [1 ,2 ]
Katori, Yukio [1 ]
Furukawa, Toru [2 ,4 ]
机构
[1] Tohoku Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med, Sendai, Japan
[2] Tohoku Univ, Dept Invest Pathol, Grad Sch Med, Sendai, Japan
[3] Gifu Univ, Dept Otolaryngol, Grad Sch Med, Sendai, Japan
[4] Tohoku Univ, Dept Invest Pathol, Grad Sch Med, 2-1 Seiryo Machi,Aoba Ku, Sendai 9808575, Japan
关键词
HPV16; Oropharyngeal carcinoma; Sublineage; DNA sequence; Vaccine; Prevention; VIRUS-LIKE PARTICLES; QUALITY-OF-LIFE; NECK-CANCER; TYPE-16; HEAD; RADIOTHERAPY; ASSOCIATION; INFECTION; PROTEIN;
D O I
10.1016/j.anl.2022.04.006
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Objective: This study aimed to investigate the distribution of human papillomavirus 16 (HPV16) variants that contribute to the development of HPV-related oropharyngeal carcinoma (HPV-OPC) in the Japanese population and to evaluate genetic variations in the sequence encoding the L1 antigen region of the viral outer shell that is targeted by existing vaccines and is relevant for designing a prevention strategy to combat the exponential increase in HPV-OPC cases in Japan.Methods: Seventy Japanese HPV-OPC patients treated at Tohoku University Hospital were included in the study. DNA was extracted from formalin-fixed, paraffin-embedded tissue samples. Polymerase chain reaction and direct nucleotide sequencing were performed to determine the nucleotide polymorphisms necessary for the classification of HPV16 variants and to assess genetic diversity in the HPV16 L1 antigen region, including the BC, DE, EF, FG, and HI loops.Results: The most common variant of HPV16 was the A4 sublineage (88.6%), conventionally called the Asian type, followed by the A1/2/3 (10.0%) sublineage, classified as the European type. The only nonsynonymous substitution detected in the L1 antigen loop region was p.N181T in the EF loop, which was found in 28/70 (40%) cases. In contrast, no nonsynonymous substitutions were observed in the DE, FG, and HI loops, which are particularly important regions in the antigen loop targeted by existing HPV vaccines.Conclusion: The most common HPV16 variant in Japanese HPV-OPC patients was the A4 subtype. The L1 antigen region is highly conserved, suggesting sufficient efficacy of existing HPV vaccines. These findings provide important information that will aid in the design of an HPV16 infection control strategy using existing HPV vaccines to prevent the spread of HPV-OPC in Japan. (c) 2022 Japanese Society of Otorhinolaryngology-Head and Neck Surgery, Inc. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1033 / 1041
页数:9
相关论文
共 50 条
  • [1] Human papillomavirus-related oropharyngeal cancer
    Taberna, M.
    Mena, M.
    Pavon, M. A.
    Alemany, L.
    Gillison, M. L.
    Mesia, R.
    ANNALS OF ONCOLOGY, 2017, 28 (10) : 2386 - 2398
  • [2] Patient-reported outcomes in human papillomavirus-related oropharyngeal cancer
    Fitzgerald, Conall W. R.
    Long, Sallie M.
    McLean, Andrew T.
    Cracchiolo, Jennifer R.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (06) : 967 - 976
  • [3] Human Papillomavirus-Related Oropharyngeal Cancer: A Review of Nursing Considerations
    McKiernan, Janet
    Thom, Bridgette
    AMERICAN JOURNAL OF NURSING, 2016, 116 (08) : 34 - 43
  • [4] How to prevent human papillomavirus-related oropharyngeal cancer?
    Ferrando-Diez, Angelica
    Pavon, Miguel Angel
    Cirauqui, Beatriz
    Alemany, Laia
    Mesia, Ricard
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (03) : 145 - 150
  • [5] Trends in human papillomavirus-related oropharyngeal cancer in Israel
    Amit, Moran
    Ilana, Kaplan
    Avraham, Sharon Pelles
    Binenbaum, Yoav
    Bachar, Gideon
    Billan, Salem
    Zaarura, Suliman
    Czerninski, Rakefet
    Bar-Tov, Matan
    Maly, Alexander
    Akrish, Sharon
    Gil, Ziv
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E274 - E278
  • [6] Human Papillomavirus-Related Oropharyngeal Cancer in Women
    Scaffidi, Rose M.
    Gerhardt, Jill
    Eisele, Cheryle
    JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2016, 61 (03) : 380 - 383
  • [7] Biology of Human Papillomavirus-Related Oropharyngeal Cancer
    Howard, Jason D.
    Chung, Christine H.
    SEMINARS IN RADIATION ONCOLOGY, 2012, 22 (03) : 187 - 193
  • [8] Hypofractionated radiation therapy alone for human papillomavirus-related oropharyngeal cancer
    Chen, Allen M.
    Harris, Jeremy P.
    Tjoa, Tjoson
    Haidar, Yarah
    Armstrong, William B.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025, 47 (01): : 235 - 241
  • [9] Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer
    Dahlstrom, Kristina R.
    Anderson, Karen S.
    Field, Matthew S.
    Chowell, Diego
    Ning, Jing
    Li, Nan
    Wei, Qingyi
    Li, Guojun
    Sturgis, Erich M.
    CANCER, 2017, 123 (24) : 4886 - 4894
  • [10] Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma
    Rettig, Eleni M.
    Wentz, Alicia
    Posner, Marshall R.
    Gross, Neil D.
    Haddad, Robert I.
    Gillison, Maura L.
    Fakhry, Carole
    Quon, Harry
    Sikora, Andrew G.
    Stott, William J.
    Lorch, Jochen H.
    Gourin, Christine G.
    Guo, Yingshi
    Xiao, Weihong
    Miles, Brett A.
    Richmon, Jeremy D.
    Andersen, Peter E.
    Misiukiewicz, Krzysztof J.
    Chung, Christine H.
    Gerber, Jennifer E.
    Rajan, Shirani D.
    D'Souza, Gypsyamber
    JAMA ONCOLOGY, 2015, 1 (07) : 907 - 915